998
M. Pellei et al. / Journal of Organometallic Chemistry 693 (2008) 996–1004
affording an orange/yellow solid. The crude product was
re-crystallized from chloroform/petroleum ether (1:4),
yielding Na[(S-tim)2CHCO2] (1) as microcrystalline nee-
(major positive-ions, CH3OH), m/z (%): 241 (80) [(S-
tim)2CHCO2 ꢀ CO2 + 2H]+, 634 (100) [{[(S-tim)2CHCO2]
Sn(C6H5)3} + H]+. ESIMS (major negative-ions, CH3OH),
m/z (%): 421 (100) [Sn(C6H5)3Cl + Cl]ꢀ. Calc. for
C28H26N4O2S2Sn: C, 53.10; H, 4.14; N, 8.85; S, 10.13.
Found: C, 52.90; H, 4.28; N, 8.69; S, 9.80%. The dichloro-
methane reaction solution of 2 was re-crystallized and the
decarboxylated species {[(S-tim)2CH2]SnCl(H2O)(C6H5)3}
(5) was obtained as a crystalline solid and characterized
by X-ray crystallography.
1
dles. Yield 75%. Mp. 110–120 °C dec. H NMR (CDCl3,
293 K): d 3.52 (s, 6H, CH3), 5.05 (s, 1H, CHCOO), 6.90
1
(s, 2H, CH), 6.97 (s, 2H, CH). H NMR (D2O, 293 K):
d 3.47 (s, 6H, CH3), 4.73 (s, 1H, CHCOO), 6.85 (d, 2H,
CH), 6.99 (d, 2H, CH). 1H NMR (D2O/DCl, 293 K):
d 3.45 (s, 6H, CH3), 6.84 (d, 2H, CH), 6.97 (d, 2H, CH).
1H NMR (CD3OD, 293 K): d 3.75 (s, 6H, CH3), 4.89 (s,
1H, CHCOO), 6.96 (d, 2H, CH), 7.15 (d, 2H, CH). 13C
NMR (CDCl3, 293 K): d 34.10 (CH3), 62.23 (CHCOO),
123.42 (CH), 129.97 (CH), 139.88 (CS), 173.14 (CHCOO).
13C NMR (D2O, 293 K): d 33.72 (CH3), 60.79 (CHCOO),
125.14 (CH), 128.94 (CH), 137.80 (CS), 173.30 (CHCOO).
13C NMR (D2O/DCl, 293 K): d 33.71 (CH3), 60.52
(CHCOO), 125.13 (CH), 128.94 (CH), 137.79 (CS),
173.27 (CHCOO). IR (Nujol, cmꢀ1): 3091w (CH),
1615sbr (masymC@O), 1506m (C@C + C@N), 1350sh
(msymC@O), 686s, 667m, 627w, 505s, 422sbr, 366m, 323w,
294m, 279w. ESIMS (major positive-ions, CH3OH), m/z
(%): 307 (100) [(S-tim)2CHCO2 + Na + H]+, 329 (80)
[(S-tim)2CHCO2 + 2Na]+, 636 (45) [{(S-tim)2CHCO2}2 +
3Na]+, 942 (30) [{(S-tim)2CHCO2}3 + 4Na]+, 1248 (10)
[{(S-tim)2CHCO2}4 + 5Na]+. ESIMS (major negative-
ions, CH3OH), m/z (%): 239 (100) [(S-tim)2CHCO2 ꢀ
CO2]ꢀ, 283 (30) [(S-tim)2CHCO2]ꢀ. ESIMS (major
positive-ions, H2O), m/z (%): 241 (15) [[(S-tim)2CHCO2] ꢀ
CO2 + 2H]+, 285 (40) [(S-tim)2CHCO2 + 2H]+, 307 (100)
[(S-tim)2CHCO2 + Na + H]+, 329 (15) [(S-tim)2CHCO2 +
2Na]+, 636 (20) [{(S-tim)2CHCO2}2 + 3Na]+, 942 (20)
[{(S-tim)2CHCO2}3 + 4Na]+. ESIMS (major negative-
ions, H2O), m/z (%): 239 (100) [(S-tim)2CHCO2 ꢀ
CO2]ꢀ, 283 (25) [(S-tim)2CHCO2]ꢀ. ESIMS (major posi-
tive-ions, H2O/CH3COOH), m/z (%): 241 (10) [[(S-
tim)2CHCO2] ꢀ CO2 + 2H]+, 285 (100) [(S-tim)2CH-
CO2 + 2H]+, 307 (20) [(S-tim)2CHCO2 + Na + H]+.
ESIMS (major negative-ions, H2O/CH3COOH), m/z
(%): 239 (100) [(S-tim)2CHCO2 ꢀ CO2]ꢀ, 283 (30) [(S-
tim)2CHCO2]ꢀ. Calc. for C10H11N4NaO2S2: C, 39.21; H,
3.62; N, 18.29; S, 20.93. Found: C, 39.04; H, 3.81; N,
18.03; S, 20.67%.
3.1.3. {[j1O-(S-tim)2CHCO2]Sn(C4H9)3} (3)
Complex 3 was prepared analogously to compound 2 by
using (C4H9)3SnCl (0.325 g, 1.0 mmol) and Na[(S-tim)2-
CHCO2] (0.306 g, 1.0 mmol) in chloroform solution
(50 mL). The yellow product was re-crystallized from chlo-
1
roform/n-hexane (1/3), in 85% yield. H NMR (CDCl3,
293 K): d 0.85–1.58 (m, 27H, Sn C4H9), 3.67 (s, 6H,
CH3), 5.34 (s, 1H, CHCOO), 6.92 (s, 2H, CH), 7.04 (s,
2H, CH). 119Sn NMR (CDCl3, 293 K): 127.96 (s). IR
(Nujol, cmꢀ1): 3136w, 3106w (CH), 1642s (masymC@O),
1511m (C@C + C@N), 1335m (msymC@O), 573s (Sn–C),
455s (Sn–O). ESIMS (major positive-ions, CH3OH), m/z
(%): 574 (100) [{[(S-tim)2CHCO2]Sn(C4H9)3} + H]+, 863
(30) [{[(S-tim)2CHCO2][Sn(C4H9)3]2}]+. ESIMS (major
negative-ions, CH3OH), m/z (%): 379 (100) [Sn(C4H9)3-
Cl(H2O) + Cl]ꢀ, 239 (40) [(S-tim)2CH]ꢀ, 857 (40) [{[(S-
tim)2CHCO2]2[Sn(C4H9)3]}]ꢀ. Calc. for C22H38N4O2S2Sn:
C, 46.08; H, 6.68; N, 9.77; S, 11.18. Found: C, 45.89; H,
6.82; N, 9.59; S, 10.98%. Re-crystallization of the crude
product from chloroform/diethyl ether (1:1) gave the
species {[j1O-(S-tim)2CHCO2]Sn(H2O)(C4H9)3} (3 ꢁ H2O)
as a crystalline solid suitable for X-ray crystallographic
study.
3.1.4. {[j1O-(S-tim)2CHCO2]Sn(C6H11)3} (4)
Compound 4 was prepared analogously to compound 2,
by using (C6H11)3SnCl (0.404 g, 1.0 mmol) and Na[(S-
tim)2CHCO2] (0.306 g, 1.0 mmol) in chloroform solution
(50 mL). The product was re-crystallized from chloro-
1
form/n-hexane. Yield: 55%. H NMR (CDCl3, 293 K): d
1.32–1.93 (m, 33H, Sn–C6H11), 3.70 (s, 6H, CH3), 5.42 (s,
119
3.1.2. {[j1O-(S-tim)2CHCO2]Sn(C6H5)3} (2)
1H, CHCOO), 6.93 (s, 2H, CH), 7.06 (s, 2H, CH).
Sn
NMR (CDCl3, 293 K): 37.76 (s). IR (Nujol, cmꢀ1):
3136w (CH), 1639s (masymC@O), 1511m (C@C + C@N),
1328s (msymC@O), 603s; 505m (Sn–C), 420mbr (Sn–O),
336m, 325s, 304m, 252m. ESIMS (major positive-ions,
CH3OH), m/z (%): 241 (70) [[(S-tim)2CHCO2] ꢀ CO2 +
2H]+, 285 (60) [(S-tim)2CHCO2 + 2H]+, 653 (100)
[{[(S-tim)2CHCO2]Sn(C6H11)3} + H]+. ESIMS (major
negative-ions, CH3OH), m/z (%): 239 (60) [(S-tim)2-
CHCO2 ꢀ CO2]ꢀ, 283 (10) [(S-tim)2CHCO2]ꢀ, 590 (60)
[{(S-tim)2CHCO2}2 + Na]ꢀ, 687 (100) [{[(S-tim)2CH-
CO2]2Sn(C6H11)3 + Cl}]ꢀ. Anal. Calc. for C28H44N4O2-
S2Sn: C, 51.62; H, 6.81; N, 8.60; S, 9.84. Found: C,
51.16; H, 7.01; N, 8.75; S, 10.02%.
To a chloroform solution (50 mL) of (C6H5)3SnCl
(0.385 g, 1.0 mmol), Na[(S-tim)2CHCO2] (0.306 g, 1.0 mmol)
was added at room temperature. After addition, the reac-
tion mixture was stirred for 4 h and then filtered; the sol-
vent was removed under vacuum and the residue was
washed with chloroform/n-hexane (1:5). The yellow prod-
uct was re-crystallized from chloroform/n-hexane. Yield:
1
43%. H NMR (CDCl3, 293 K): d 3.50 (s, 6H, CH3), 5.32
(s, 1H, CHCOO), 6.83 (s, 2H, CH), 7.03 (s, 2H, CH),
7.44–7.71 (m, 15H, Sn–C6H5). 119Sn NMR (CDCl3,
293 K): ꢀ95.83 (s). IR (Nujol, cmꢀ1): 3116w (CH), 1656s
(masymC@O), 1508m (C@C + C@N), 1308s (msymC@O),
456s (Ph), 444m, 429m (Sn–O), 278s, 245s (Sn–C). ESIMS